As a result, the technology stands at a complicated intersection in the fight against a shifting climate. Breeding plants to ...
Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for ...
Cellectis’ headquarters are in Paris, France, with locations in New York and Raleigh, NC. Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on Euronext Growth (ticker: ALCLS). To find ...
An animal geneticist at the University of California-Davis told Kansas cattle producers recently that a gene editing technique more common in plant genetics is also a safe option for shortening the ...
Preclinical data demonstrates proof-of-concept for EDIT-401 with ≥90% mean LDL-C reduction in non-human primates and mouse ...
To extend shelf life and reduce food waste, scientists at U.K.-based biotech company Tropic introduced the first non-browning ...
The company is gene editing crops to make our food supply more resilient to climate change.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback